Free Shipping on orders over $150
1
Awaiting product image

BPC-157 — 10mg

Pentadecapeptide / Gastric Origin

BPC-157 is a synthetic peptide carrying an active body of indexed research literature, with 222 PubMed records to date spanning 156 animal studies, 49 human studies, and 2 clinical studies.

$30.00

A synthetic pentadecapeptide studied in preclinical research for tissue repair and gut healing. Research use only.

SKU: LL-BPC157-10 Category:

PubMed Literature Index

222

studies indexed in the public literature

Q2 2026 · view PubMed search ↗

49
Human
156
Animal
2
Clinical Trials
0
EU Trials

Overview

In the literature, BPC-157 is described not as a classical receptor agonist binding a single defined target, but as a proposed biological signaling orchestrator. Studies describe upregulation of receptor expression, activation of downstream signaling cascades, and modulation of neurotransmitter receptor sensitivity as components of this proposed activity. Researchers characterize this as a multi-pathway mechanism, distinguishing it from single-target receptor pharmacology and framing its study across multiple tissue types rather than one isolated system.

Chemical & Molecular Properties

FormulaC62H98N16O22
Mol. Weight1419.5 g/mol
PubChem CID9941957

Key Areas of Research Interest

  • Investigated in the context of receptor expression regulation
  • Investigated in the context of downstream intracellular signaling cascade activation
  • Investigated in the context of neurotransmitter receptor sensitivity modulation
  • Investigated in the context of multi-tissue, multi-pathway signaling rather than single-target activity
  • Subject of a substantial indexed literature base, including preclinical (animal) and limited clinical human studies

FAQ

What is BPC-157 commonly researched for?

BPC-157 is studied in the literature for its proposed role as a multi-pathway biological signaling orchestrator, including research into receptor expression regulation, downstream signaling cascade activation, and neurotransmitter receptor sensitivity, across a body of 222 indexed PubMed records spanning animal and human studies. It is sold strictly for laboratory research use, not for human or animal consumption.

Is BPC-157 FDA-approved?

No. Sold for laboratory research use only, not FDA-approved, not for human or veterinary consumption.

How is BPC-157 stored?

Lyophilized and frozen, protected from light; refrigerated after reconstitution for research use.

What purity standard does Legendary Labz hold BPC-157 to?

Every lot of BPC-157 is independently third-party tested to verify purity and identity before release.

Is a Certificate of Analysis available for BPC-157?

Yes. Certificates of Analysis are published per lot as testing completes, and Legendary Labz is Sourced in the USA.

Materials referenced on this page are intended for laboratory research purposes. No claims regarding therapeutic efficacy are made or implied. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.

Description

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide, a chain of 15 amino acids derived from a protective protein found naturally in human gastric juice. In preclinical research it has been studied for its effects on tissue repair, angiogenesis, and modulation of nitric-oxide signaling, appearing to act locally with a systemic amplification effect. Human data remains limited to small pilot studies (fewer than 30 participants across all studies); large-scale randomized controlled trials have not been completed.

Research Findings

Areas examined in the preclinical literature include:

  • Acceleration of tendon, ligament, and muscle healing in animal models, with limited human pilot data.
  • Repair of gut lining, including small pilot data in interstitial cystitis.
  • Anti-inflammatory activity via nitric-oxide and VEGF pathways.
  • Neuroprotective effects supporting CNS and peripheral nerve recovery in animal models.
  • Bone density and joint-integrity improvements in animal models.

Structure & Chemistry

  • Class: Pentadecapeptide (15-amino-acid sequence)
  • Molecular formula: C₆₂H₉₈N₁₆O₂₂
  • Molecular weight: 1419.53 g/mol
  • Approximate size: ~1.8 kDa
  • Solubility: Water-soluble; stable in solution (slightly acidic, pH ~5–6)

Regulatory & Research Status

  • FDA Category 2 (2023): cannot be legally compounded in the US for commercial use.
  • WADA Prohibited (2022): listed under S0 Non-Approved Substances.
  • Human evidence is limited to small pilot studies; no completed Phase 2/3 RCTs.
  • Findings above are drawn primarily from animal and in-vitro studies. Human clinical confirmation is pending.

Specifications

Presentation 10 mg lyophilized peptide, single vial
Purity >99% by HPLC
Form Lyophilized powder (reconstitute with bacteriostatic water for laboratory use)
Category Systemic repair / GI research
For laboratory and research use only. Not for human or animal consumption. Not approved by the FDA for any therapeutic use. No claims regarding therapeutic efficacy are made or implied. Must be 21 or older.

Reviews

There are no reviews yet.

Be the first to review “BPC-157 — 10mg”

Your email address will not be published. Required fields are marked *

Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide, a chain of 15 amino acids derived from a protective protein found naturally in human gastric juice. In preclinical research it has been studied for its effects on tissue repair, angiogenesis, and modulation of nitric-oxide signaling, appearing to act locally with a systemic amplification effect. Human data remains limited to small pilot studies (fewer than 30 participants across all studies); large-scale randomized controlled trials have not been completed.

Research Findings

Areas examined in the preclinical literature include:

  • Acceleration of tendon, ligament, and muscle healing in animal models, with limited human pilot data.
  • Repair of gut lining, including small pilot data in interstitial cystitis.
  • Anti-inflammatory activity via nitric-oxide and VEGF pathways.
  • Neuroprotective effects supporting CNS and peripheral nerve recovery in animal models.
  • Bone density and joint-integrity improvements in animal models.

Structure & Chemistry

  • Class: Pentadecapeptide (15-amino-acid sequence)
  • Molecular formula: C₆₂H₉₈N₁₆O₂₂
  • Molecular weight: 1419.53 g/mol
  • Approximate size: ~1.8 kDa
  • Solubility: Water-soluble; stable in solution (slightly acidic, pH ~5–6)

Regulatory & Research Status

  • FDA Category 2 (2023): cannot be legally compounded in the US for commercial use.
  • WADA Prohibited (2022): listed under S0 Non-Approved Substances.
  • Human evidence is limited to small pilot studies; no completed Phase 2/3 RCTs.
  • Findings above are drawn primarily from animal and in-vitro studies. Human clinical confirmation is pending.

Specifications

Presentation 10 mg lyophilized peptide, single vial
Purity >99% by HPLC
Form Lyophilized powder (reconstitute with bacteriostatic water for laboratory use)
Category Systemic repair / GI research
For laboratory and research use only. Not for human or animal consumption. Not approved by the FDA for any therapeutic use. No claims regarding therapeutic efficacy are made or implied. Must be 21 or older.

Related Research